Clinical delivery of circular RNA: lessons learned from RNA drug development

TL Young, KC Wang, AJ Varley, B Li - Advanced drug delivery reviews, 2023 - Elsevier
Circular RNAs (circRNA) represent a distinct class of covalently closed-loop RNA molecules,
which play diverse roles in regulating biological processes and disease states. The …

[HTML][HTML] Potential implications of miRNAs in the pathogenesis, diagnosis, and therapeutics of Alzheimer's disease

L Wang, X Shui, Y Diao, D Chen, Y Zhou… - International Journal of …, 2023 - mdpi.com
Alzheimer's disease (AD) is a complex multifactorial disorder that poses a substantial
burden on patients, caregivers, and society. Considering the increased aging population …

Tackling TNF-α in autoinflammatory disorders and autoimmune diseases: from conventional to cutting edge in biologics and RNA-based nanomedicines

V Andretto, S Dusi, S Zilio, M Repellin, D Kryza… - Advanced Drug Delivery …, 2023 - Elsevier
Autoinflammatory disorders and autoimmune diseases result from abnormal deviations of
innate and adaptive immunity that heterogeneously affect organs and clinical phenotypes …

RNAJP: enhanced RNA 3D structure predictions with non-canonical interactions and global topology sampling

J Li, SJ Chen - Nucleic acids research, 2023 - academic.oup.com
RNA 3D structures are critical for understanding their functions. However, only a limited
number of RNA structures have been experimentally solved, so computational prediction …

Engineered lipid nanoparticles for the treatment of pulmonary fibrosis by regulating epithelial‐mesenchymal transition in the lungs

H Jin, M Jeong, G Lee, M Kim, Y Yoo… - Advanced Functional …, 2023 - Wiley Online Library
Pulmonary fibrosis is a chronic and irreversible lung disease with limited therapeutic
regimens. Advances in elucidating the pathophysiological mechanism and discovering …

[HTML][HTML] Enabling mRNA therapeutics: Current landscape and challenges in manufacturing

M Youssef, C Hitti, J Puppin Chaves Fulber, AA Kamen - Biomolecules, 2023 - mdpi.com
Recent advances and discoveries in the structure and role of mRNA as well as novel lipid-
based delivery modalities have enabled the advancement of mRNA therapeutics into the …

Clinical Pharmacology of RNA Interference–Based Therapeutics: A Summary Based on Food and Drug Administration–Approved Small Interfering RNAs

X Jing, V Arya, KS Reynolds, H Rogers - Drug Metabolism and Disposition, 2023 - ASPET
RNA-based oligonucleotide therapeutics are revolutionizing drug development for disease
treatment. This class of therapeutics differs from small molecules and protein therapeutics in …

Lipid‐Peptide‐mRNA Nanoparticles Augment Radioiodine Uptake in Anaplastic Thyroid Cancer

Q Li, L Zhang, J Lang, Z Tan, Q Feng, F Zhu… - Advanced …, 2023 - Wiley Online Library
Restoring sodium iodide symporter (NIS) expression and function remains a major
challenge for radioiodine therapy in anaplastic thyroid cancer (ATC). For more efficient …

[HTML][HTML] Comprehensive evaluation of zwitterionic hydrophilic liquid chromatography stationary phases for oligonucleotide characterization

H Lardeux, D Guillarme, V D'Atri - Journal of Chromatography A, 2023 - Elsevier
Hydrophilic interaction chromatography (HILIC) has been proposed as a valuable
alternative to ion-pairing reversed-phase chromatography (IP-RPLC) for oligonucleotide …

Inhaled RNA drugs to treat lung diseases: Disease-related cells and nano–bio interactions

M Zhang, H Lu, L Xie, X Liu, D Cun, M Yang - Advanced Drug Delivery …, 2023 - Elsevier
In recent years, RNA-based therapies have gained much attention as biomedicines due to
their remarkable therapeutic effects with high specificity and potency. Lung diseases offer a …